Gluconorm-PG-L2 Tablet SR
Marketer
Lupin Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (7.5mg)
Overview Gluconorm-PG-L2 Tablet SR
Metformin and Glimepiride extended-release tablets are a dual-action medication managing blood glucose. This treatment, used alongside diet and exercise, enhances glycemic control in adult patients with type 2 diabetes. It improves insulin effectiveness, consequently reducing blood sugar. Adhere strictly to your physician's prescribed dosage and regimen. Ingestion with food mitigates potential stomach discomfort. For missed doses, take immediately unless nearing the next scheduled dose; then omit the missed one and resume the regular schedule. Never double the dose. Overdosage can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other antidiabetic medications, alcohol consumption, or meal skipping elevates hypoglycemia risk. Regular blood glucose monitoring is crucial. Common adverse reactions include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation. Renal function will be assessed before treatment initiation. Limit alcohol consumption to minimize potential adverse event risk.
Uses of Gluconorm-PG-L2 Tablet SR
Managing type 2 diabetes
Major Benefits of Gluconorm-PG-L2 Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Gluconorm-PG-L2 Tablet SR with a meal.
Common Side effects of Gluconorm-PG-L2 Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Gluconorm-PG-L2 Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gluconorm-PG-L2 Tablet SR should be administered with a meal.
How Gluconorm-PG-L2 Tablet SR works:
Gluconorm-PG-L2 SR tablets contain a triple-action antidiabetic formula: glimepiride, metformin, and pioglitazone. These medications employ distinct mechanisms to optimize blood glucose management when monotherapy or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use and Gluconorm-PG-L2 Tablet SR is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Gluconorm-PG-L2 Tablet SR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against these risks prior to prescribing. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Gluconorm-PG-L2 tablets are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Gluconorm-PG-L2 SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Gluconorm-PG-L2 SR tablet use. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when using Gluconorm-PG-L2 Tablet SR; dosage modification may be necessary. A physician's consultation is advised. Gluconorm-PG-L2 Tablet SR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Gluconorm-PG-L2 Tablet SR :
Should you forget a Gluconorm-PG-L2 Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gluconorm-PG-L2 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |






